TGX Insider Trading Activity and SEC Form 4 Filings
TGX insider trading summary
No open-market insider purchases or sales of Theragenics Corp (TGX) have been reported on SEC Form 4 in the past 12 months.
Latest TGX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 3, 2010 | K Wyatt Engwall | Director | Buy | $1K (1,250 @ $1.16) |
| Jun 1, 2010 | K Wyatt Engwall | Director | Buy | $31K (26,200 @ $1.19) |
| May 19, 2010 | Peter A A Saunders | Director | Buy | $7K (5,000 @ $1.33) |
| Feb 19, 2010 | K Wyatt Engwall | Director | Buy | $67K (50,000 @ $1.35) |
| Mar 6, 2009 | Charles D Moody Jr | Director | Buy | $21K (23,166 @ $0.90) |
| Mar 5, 2009 | John V Herndon | Director | Buy | $5K (5,000 @ $0.92) |
| Feb 27, 2009 | Peter A A Saunders | Director | Buy | $5K (5,000 @ $0.95) |
| Nov 6, 2008 | K Wyatt Engwall | Director | Buy | $30K (21,100 @ $1.41) |
| Nov 5, 2008 | Francis J Tarallo | Chief Financial Officer | Buy | $6K (3,500 @ $1.62) |
| Nov 4, 2008 | M Christine Jacobs | Chief Executive Officer | Buy | $17K (10,000 @ $1.74) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.